aTyr Pharma reported earnings of -$ 7.43 per ATYR share on Nov 5, 2026, beating analysts' expectations by
| Report Date | Nov 5, 2026 |
|---|---|
| Forecasted EPS | -$ 4.40 |
| Earnings Per Share (Surprise) | -$ 7.43 (-$ 3.03) |
| Last Year's EPS | -$ 0.20 |
| EPS YoY Change |
Out of the last 43 earnings reporting periods, aTyr Pharma beat analysts’ expectations 11 times and fell short of expectations 7 time(s). aTyr Pharma reported earnings per share of -$ 7.43 in the last report falling to reach an estimated EPS of -$ 4.40 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 4.40 | -$ 7.43 | -$ 0.26 | |
| Aug 7, 2026 | -$ 0.12 | -$ 0.11 | -$ 0.22 | |
| May 15, 2026 | -$ 0.16 | -$ 0.11 | -$ 0.17 | |
| Mar 5, 2026 | -$ 0.18 | -$ 0.14 | -$ 0.18 | |
| Nov 6, 2025 | -$ 0.20 | -$ 0.26 | -$ 0.23 | |
| Aug 7, 2025 | -$ 0.18 | -$ 0.22 | -$ 0.23 | |
| May 7, 2025 | -$ 0.19 | -$ 0.17 | -$ 0.23 | |
| Mar 13, 2025 | -$ 0.23 | -$ 0.18 | -$ 0.25 | |
| Nov 7, 2024 | -$ 0.22 | -$ 0.23 | -$ 0.20 | |
| Aug 13, 2024 | -$ 0.22 | -$ 0.23 | -$ 0.22 | |
| May 2, 2024 | -$ 0.24 | -$ 0.23 | -$ 0.29 | |
| Mar 14, 2024 | -$ 0.24 | -$ 0.25 | -$ 0.26 | |
| Sep 30, 2023 | -$ 0.23 | -$ 0.20 | -$ 0.46 | |
| Jun 30, 2023 | -$ 0.28 | -$ 0.22 | -$ 0.44 | |
| Mar 31, 2023 | -$ 0.35 | -$ 0.29 | -$ 1.54 | |
| Mar 9, 2023 | -$ 0.48 | -$ 0.26 | -$ 1.47 | |
| Nov 10, 2022 | -$ 0.46 | -$ 0.46 | -$ 1.80 | |
| Aug 15, 2022 | -$ 0.38 | -$ 0.44 | -$ 2.54 | |
| Dec 31, 2019 | - | -$ 1.54 | -$ 2.92 | |
| Sep 30, 2019 | - | -$ 1.47 | -$ 3.33 |
aTyr Pharma’s stock was trading at $ 6.18 on Nov 4, 2026 a day before the last earnings report was released.Following the release of the earnings report, ATYR’s price increased to $ 6.35 on Nov 6, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 5, 2026 | -$ 7.43 | $ 6.18 | $ 6.35 | |
| Aug 7, 2026 | -$ 0.11 | $ 0.502 | $ 0.5289 | |
| May 15, 2026 | -$ 0.11 | $ 0.5599 | $ 0.5195 | |
| Mar 5, 2026 | -$ 0.14 | $ 0.9645 | $ 0.824 | |
| Nov 6, 2025 | -$ 0.26 | $ 0.8138 | $ 0.8169 | |
| Aug 7, 2025 | -$ 0.22 | $ 5.34 | $ 5.30 | |
| May 7, 2025 | -$ 0.17 | $ 3.23 | $ 3.34 | |
| Mar 13, 2025 | -$ 0.18 | $ 3.55 | $ 3.97 | |
| Nov 7, 2024 | -$ 0.23 | $ 3.25 | $ 3.12 | |
| Aug 13, 2024 | -$ 0.23 | $ 1.81 | $ 1.85 |
aTyr Pharma released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
aTyr Pharma missed analysts’ expectations during the last earnings period by
